180 related articles for article (PubMed ID: 27083182)
1. Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.
Purrington KS; Visscher DW; Wang C; Yannoukakos D; Hamann U; Nevanlinna H; Cox A; Giles GG; Eckel-Passow JE; Lakis S; Kotoula V; Fountzilas G; Kabisch M; Rüdiger T; Heikkilä P; Blomqvist C; Cross SS; Southey MC; Olson JE; Gilbert J; Deming-Halverson S; Kosma VM; Clarke C; Scott R; Jones JL; Zheng W; Mannermaa A; ; Eccles DM; Vachon CM; Couch FJ
Breast Cancer Res Treat; 2016 May; 157(1):117-31. PubMed ID: 27083182
[TBL] [Abstract][Full Text] [Related]
2. Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype.
Funakoshi Y; Wang Y; Semba T; Masuda H; Hout D; Ueno NT; Wang X
PLoS One; 2019; 14(9):e0222336. PubMed ID: 31532791
[TBL] [Abstract][Full Text] [Related]
3. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.
Jézéquel P; Loussouarn D; Guérin-Charbonnel C; Campion L; Vanier A; Gouraud W; Lasla H; Guette C; Valo I; Verrièle V; Campone M
Breast Cancer Res; 2015 Mar; 17():43. PubMed ID: 25887482
[TBL] [Abstract][Full Text] [Related]
4. Potential prognostic tumor biomarkers in triple-negative breast carcinoma.
Peng Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):666-72. PubMed ID: 23073572
[TBL] [Abstract][Full Text] [Related]
5. Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach.
Bareche Y; Buisseret L; Gruosso T; Girard E; Venet D; Dupont F; Desmedt C; Larsimont D; Park M; Rothé F; Stagg J; Sotiriou C
J Natl Cancer Inst; 2020 Jul; 112(7):708-719. PubMed ID: 31665482
[TBL] [Abstract][Full Text] [Related]
6. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
[TBL] [Abstract][Full Text] [Related]
7. Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
Casbas-Hernandez P; Sun X; Roman-Perez E; D'Arcy M; Sandhu R; Hishida A; McNaughton KK; Yang XR; Makowski L; Sherman ME; Figueroa JD; Troester MA
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):406-14. PubMed ID: 25465802
[TBL] [Abstract][Full Text] [Related]
8. Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis.
Bareche Y; Venet D; Ignatiadis M; Aftimos P; Piccart M; Rothe F; Sotiriou C
Ann Oncol; 2018 Apr; 29(4):895-902. PubMed ID: 29365031
[TBL] [Abstract][Full Text] [Related]
9. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
Amara D; Wolf DM; van 't Veer L; Esserman L; Campbell M; Yau C
Breast Cancer Res Treat; 2017 Jan; 161(1):41-50. PubMed ID: 27815749
[TBL] [Abstract][Full Text] [Related]
10. Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers.
Masuda H; Baggerly KA; Wang Y; Iwamoto T; Brewer T; Pusztai L; Kai K; Kogawa T; Finetti P; Birnbaum D; Dirix L; Woodward WA; Reuben JM; Krishnamurthy S; Symmans W; Van Laere SJ; Bertucci F; Hortobagyi GN; Ueno NT
Breast Cancer Res; 2013 Nov; 15(6):R112. PubMed ID: 24274653
[TBL] [Abstract][Full Text] [Related]
11. Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer.
Yamashita Y; Nishiumi S; Kono S; Takao S; Azuma T; Yoshida M
BMC Cancer; 2017 Aug; 17(1):589. PubMed ID: 28851309
[TBL] [Abstract][Full Text] [Related]
12. Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer.
Díaz-Martín J; López-García MÁ; Romero-Pérez L; Atienza-Amores MR; Pecero ML; Castilla MÁ; Biscuola M; Santón A; Palacios J
Endocr Relat Cancer; 2015 Jun; 22(3):443-54. PubMed ID: 25870251
[TBL] [Abstract][Full Text] [Related]
13. Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression.
Stricker TP; Brown CD; Bandlamudi C; McNerney M; Kittler R; Montoya V; Peterson A; Grossman R; White KP
PLoS Genet; 2017 Mar; 13(3):e1006589. PubMed ID: 28263985
[TBL] [Abstract][Full Text] [Related]
14. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
[TBL] [Abstract][Full Text] [Related]
15. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
[TBL] [Abstract][Full Text] [Related]
16. Identification of a metabolic and canonical biomarker signature in Mexican HR+/HER2-, triple positive and triple-negative breast cancer patients.
Pacheco-Velázquez SC; Gallardo-Pérez JC; Aguilar-Ponce JL; Villarreal P; Ruiz-Godoy L; Pérez-Sánchez M; Marín-Hernández A; Ruiz-García E; Meneses-García A; Moreno-Sánchez R; Rodríguez-Enríquez S
Int J Oncol; 2014 Dec; 45(6):2549-59. PubMed ID: 25270118
[TBL] [Abstract][Full Text] [Related]
17. A novel subtype classification and risk of breast cancer by histone modification profiling.
Chen X; Hu H; He L; Yu X; Liu X; Zhong R; Shu M
Breast Cancer Res Treat; 2016 Jun; 157(2):267-279. PubMed ID: 27178334
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.
Iwase H; Kurebayashi J; Tsuda H; Ohta T; Kurosumi M; Miyamoto K; Yamamoto Y; Iwase T
Breast Cancer; 2010 Apr; 17(2):118-24. PubMed ID: 19466512
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of basal-like and non-basal-like triple-negative breast cancer.
Prat A; Adamo B; Cheang MC; Anders CK; Carey LA; Perou CM
Oncologist; 2013; 18(2):123-33. PubMed ID: 23404817
[TBL] [Abstract][Full Text] [Related]
20. Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence.
Ortiz-Martínez F; Perez-Balaguer A; Ciprián D; Andrés L; Ponce J; Adrover E; Sánchez-Payá J; Aranda FI; Lerma E; Peiró G
Hum Pathol; 2014 Mar; 45(3):504-12. PubMed ID: 24440093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
